NURECA LIMITED IPO
Nureca Limited, incorporated in 2016, is a B2C company that is engaged in home healthcare & wellness products. Its products offer quality, functionality, durability, usability, and innovative designs. Nureca limited enables their customers with the tools which help to monitor the chronic alignments or other diseases to improve the lifestyle of the user. The company believes in innovation and catering new & innovative products for the ever-growing needs in the home healthcare sector.
It is a digital-first company that sells its products through online channel partners which include e-commerce players, retailers, and distributors. It also sells its products through its own website drtrust.in.
Nureca limited has a diversified portfolio of products that primarily caters to the home healthcare sector. Its product portfolio includes chronic device products, orthopedic products, mother & child products, nutrition supplements, and lifestyle products.
The company has shown a growth of 60.50% and 2.73% in their revenue and profit for the FY2020 over the FY2019. The Companie’s net profit has shown growth with a CAGR of 43.35% during the fiscal year 2018 to 2020.
The promoter of the company is Mr. Saurabh Goyal.
Strengths of the company
- The company has a diversified portfolio of products catering to the needs of different customers across the industry of home healthcare.
- The company is a well-recognized brand having a targeted marketing strategy.
- The company has a wide sales and diversified distribution network across India.
- The promoters of the company are well-experienced and have a strong management team with domain knowledge.
- The company has a strong track record with robust financial performance.
Purpose of the IPO
- To meet the incremental working capital requirement of the company.
- For general corporate purposes.
Financial Performance of the company
| For the period ended 30th June 2020 | FY 2020 | FY 2019 | FY 2018 | |
| Total Revenue | 30.38 | 99.48 | 61.98 | 20.06 |
| Total Expenses | 17.68 | 90.87 | 53.14 | 15.74 |
| Profit after tax | 9.44 | 6.39 | 6.22 | 3.11 |
| Total Assets | 42.58 | 33.88 | 23.51 | 7.01 |
*All the values are in crores and as per DRHP.
Valuation of the company
| For the period ended 30th June 2020 | FY 2020 | FY 2019 | FY 2018 | |
| Basic Earnings per Share (EPS) | 13.50 | 9.14 | 8.89 | 4.45 |
| Diluted Earnings per Share (EPS) | 13.50 | 9.14 | 8.89 | 4.45 |
| Return on Net Worth (%) | 38.74% | 42.82% | 78.36% | 180.93% |
| Net Assets Value per Equity Share | 243.86 | 14,934.00 | 7,945.00 | 1,720.00 |
*as per DRHP
IPO details
| Face Value | ₹10 Per Equity Share |
| Market Lot | 35 Shares |
| Minimum Order Quantity | 35 Shares |
| Price Band | ₹396 - ₹400 Per Equity Share |
| Issue type | Book Built Issue IPO |
| Issue Size | ₹100 Crores |
| Fresh Issue | ₹100 Crores |
| Offer for Sale | - |
| Listing | BSE, NSE |
*Employee discount ₹20 per share.
Important IPO dates
| Open Date | 15th February 2021 |
| Close Date | 17th February 2021 |
| Allotment Date | 23rd February 2021 |
| Initiation of Refunds | 24th February 2021 |
| The credit of shares to Demat Account | 25th February 2021 |
| Listing Date | 26th February 2021 |
Allocation Quota
| Category | Portion |
| Qualified Institutional Buyers (QIBs) | 75% |
| Non- Institutional Buyers (NIIs) | 15% |
| Retail Investors | 10% |
Check your Nureca LTD IPO allotment status here:
Linkline IPO allotment Status: Click here
BSE IPO Allotment Status: Click here
NSE IPO Allotment Status: Click here